Le Lézard
Classified in: Health, Science and technology
Subjects: Product/Service, Award

Kwello Insights, Powered by ElsieAI, Honored as Stevie® Award Winner


Kwello's ElsieAI was named the winner of multiple Bronze Stevie® Awards in the Healthcare Technology Solution and Artificial Intelligence/Machine Learning Solution categories in The 22nd Annual American Business Awards® today.

"It's evident that the platform represents a significant advancement in generative AI for data analysis within the pharmaceutical sector," said a panel of American Business Award judges. "Developed as part of Kwello by Acceleration Point, ElsieAI addresses a critical need within the Medical Affairs field by providing a solution that can transform vast amounts of medical insights into actionable strategies for drug development and patient care improvement."

The American Business Awards are the U.S.A.'s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations ? public and private, for-profit and non-profit, large and small.

ElsieAI leverages the power of Generative Artificial Intelligence and an intuitive interface, empowering Medical Affairs teams to effortlessly extract valuable insights from complex insight data. With ElsieAI, users can engage in a chat-like conversation with their internal insights data using plain language, allowing you to uncover key trends, summaries, and next best actions. ElsieAI is medically trained to navigate the intricacies of scientific information, providing Medical Affairs teams with actionable steps and clear-cut interpretations of complex insights data.

"It's fantastic to see Kwello Insights, powered by ElsieAI, recognized with a Bronze Stevie® Award," said Catherine Wright, VP of Product at Kwello. "It's been incredible to see how our customers are leveraging ElsieAI since launch and how it has transformed their approach to Medical Affairs analytics. At Kwello, we're excited to keep pushing the boundaries with new features that empower our users to turn complex data into actionable insights, improving patient care and advancing science."

About Kwello

Kwello, a division of Acceleration Point is a leading provider of insight solutions for Medical Affairs teams. Our mission is to help Medical Affairs teams learn from top KOLs around the world. We are committed to revolutionizing the process of gathering, analyzing, and leveraging insights within the pharmaceutical industry, ensuring that every piece of information serves to advance patient care and organizational success. Kwello is global company with offices in Roanoke, Virginia and London, United Kingdom.

For more information, please visit www.accelerationpoint.com/kwello.


These press releases may also interest you

at 05:35
HighField Biopharmaceuticals, a clinical stage company using lipid-based therapeutics to treat cancer, diabetes and other diseases, announced today that its abstract of preclinical data evaluating an mRNA-based GLP-1R agonist (HFG1) in diabetic...

at 05:35
Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for metabolic and inflammatory diseases, such as gout, is calling for increased understanding of the dangers of...

at 05:25
RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently announced significant progress of Telitacicept (RC18), that two Phase III clinical trials in China for the treatment of IgA...

at 05:00
So-Young International Inc. ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its...

at 05:00
OutcomeMD has emerged as a pioneering force, redefining the way patient-reported outcomes (PROs) are utilized in healthcare. Unlike traditional players in the market who focus primarily on aiding physicians with research, OutcomeMD has carved out a...

at 04:35
A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technology (iHealthtech) has unveiled a novel approach to stimulate muscle, by way of using brief and mild pulsed electromagnetic...



News published on and distributed by: